All In Biotech

Drug Trial Radar · NCT04430283

Evaluation of FDY-5301 in Major Trauma Patients in ICU

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Intravenous FDY-5301 for the Prevention and Treatment of ICU Acquired Weakness in Major Trauma Patients.

Last checked: Nov 19, 2026Latest source record: Jun 13, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

8

Actual

Start

Sep 20, 2021

Primary completion

Mar 4, 2022

Study completion Mar 4, 2022

Sponsor

Lead sponsor
Faraday Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Jun 12, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of FDY-5301 compared to placebo in major trauma ICU patients at risk of intensive care unit acquired weakness (ICUAW)

Conditions

  • ICU Acquired Weakness

Interventions

  • FDY-5301Drug

    FDY-5301 is Sodium Iodide administered as an isotonic solution for intravenous injection with a concentration of 7.2 mg/ml.

  • PlaceboOther

    Placebo is delivered as a single dose, non-reserved liquid parenteral consisting of a formulation matched compendial saline.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Chelsea Critical Care Physical Assessment ToolTime frame: Day 10 or hospital discharge, whichever occurs first.
  2. Organ Dysfunction Total Time to RecoveryTime frame: Day 28 or hospital discharge, whichever occurs first.

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Harbor-UCLA Medical Center

    Torrance, California

  • University of Florida Health Shands Hospital

    Gainesville, Florida

  • Massachusetts General Hospital, Harvard Medical School

    Boston, Massachusetts

  • The Ohio State University Wexner Medical Center

    Columbus, Ohio

  • Harborview

    Seattle, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.